This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1985;23(3):325-35.

doi: 10.1016/0005-7967(85)90011-7.

Combined pharmacological and behavioral treatment for agoraphobia

M J Telch, W S Agras, C B Taylor, W T Roth, C C Gallen

PMID: 2860892
DOI: 10.1016/0005-7967(85)90011-7

Clinical Trial

Combined pharmacological and behavioral treatment for agoraphobia

M J Telch et al. Behav Res Ther. 1985.

. 1985;23(3):325-35.

doi: 10.1016/0005-7967(85)90011-7.

Authors

M J Telch, W S Agras, C B Taylor, W T Roth, C C Gallen

PMID: 2860892
DOI: 10.1016/0005-7967(85)90011-7

No abstract available

PubMed Disclaimer

Similar articles

Clinically significant improvement in agoraphobia research.
Mavissakalian M. Mavissakalian M. Behav Res Ther. 1986;24(3):369-70. doi: 10.1016/0005-7967(86)90198-1. Behav Res Ther. 1986. PMID: 2873811 Clinical Trial. No abstract available.
Combined behavioral therapy and pharmacotherapy of agoraphobia.
Mavissakalian M. Mavissakalian M. J Psychiatr Res. 1993;27 Suppl 1:179-91. doi: 10.1016/0022-3956(93)90027-y. J Psychiatr Res. 1993. PMID: 7908332 Review.
Panic and avoidance in agoraphobia. Application of path analysis to treatment studies.
Klein DF, Ross DC, Cohen P. Klein DF, et al. Arch Gen Psychiatry. 1987 Apr;44(4):377-85. doi: 10.1001/archpsyc.1987.01800160093011. Arch Gen Psychiatry. 1987. PMID: 2882736 Clinical Trial.
Treating agoraphobia.
Barley WD. Barley WD. Hosp Community Psychiatry. 1984 Jul;35(7):733. doi: 10.1176/ps.35.7.733. Hosp Community Psychiatry. 1984. PMID: 6146561 No abstract available.
Differential effects of imipramine and behavior therapy on panic disorder with agoraphobia.
Mavissakalian M. Mavissakalian M. Psychopharmacol Bull. 1989;25(1):27-9. Psychopharmacol Bull. 1989. PMID: 2672069 Review. No abstract available.

See all similar articles

Cited by

The utility of the panic disorder concept.
Klein DF, Klein HM. Klein DF, et al. Eur Arch Psychiatry Neurol Sci. 1989;238(5-6):268-79. doi: 10.1007/BF00449808. Eur Arch Psychiatry Neurol Sci. 1989. PMID: 2670574 Review.
Beta-receptor responsiveness after desipramine treatment.
Pohl R, Pandey GN, Yeragani VK, Balon R, Davis JM, Berchou R. Pohl R, et al. Psychopharmacology (Berl). 1993;110(1-2):37-44. doi: 10.1007/BF02246948. Psychopharmacology (Berl). 1993. PMID: 7870896 Clinical Trial.
Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Guaiana G, Meader N, Barbui C, Davies SJ, Furukawa TA, Imai H, Dias S, Caldwell DM, Koesters M, Tajika A, Bighelli I, Pompoli A, Cipriani A, Dawson S, Robertson L. Guaiana G, et al. Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012729. doi: 10.1002/14651858.CD012729.pub3. Cochrane Database Syst Rev. 2023. PMID: 38014714 Free PMC article.
Eight years later: outcomes of CBT-treated versus untreated anxious children.
Adler Nevo GW, Avery D, Fiksenbaum L, Kiss A, Mendlowitz S, Monga S, Manassis K. Adler Nevo GW, et al. Brain Behav. 2014 Sep;4(5):765-74. doi: 10.1002/brb3.274. Epub 2014 Aug 19. Brain Behav. 2014. PMID: 25328851 Free PMC article.
A risk-benefit assessment of buspirone in the treatment of anxiety disorders.
Pecknold JC. Pecknold JC. Drug Saf. 1997 Feb;16(2):118-32. doi: 10.2165/00002018-199716020-00004. Drug Saf. 1997. PMID: 9067123 Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information